Literature DB >> 34661743

Regulatory role of miR-129 and miR-384-5p on apoptosis induced by oxygen and glucose deprivation in PC12 cell.

Hui-Lin Guan1, Yue Guan2, Wen-Yuan Li3, Jia-Wei Liu4, Yu-Jia Zheng5, Yan-Zhong Guan6, Hong-Feng Liu7, Li-Xin Guan8,9, Feng-Guo Zhai10,11.   

Abstract

This study aimed to establish the role of miR-129 and miR-384-5p in cerebral ischemia-induced apoptosis. Using PC12 cells transfected with miR-129 or miR-384-5p mimics or inhibitors, oxygen glucose deprivation (OGD) conditions were applied for 4 h to simulate transient cerebral ischemia. Apoptotic phenotypes were assessed via lactate dehydrogenase (LDH) assay, MTT cell metabolism assay, and fluorescence-activated cell sorting (FACS). The effect of miR overexpression and inhibition was evaluated by protein and mRNA detection of bcl-2 and caspase-3, critical apoptosis factors. Finally, the direct relationship of miR-129 and bcl-2 and miR-384-5p and caspase-3 was measured by luciferase reporter assay. The overexpression of miR-384-5p and miR-129 deficiency significantly enhanced cell viability, reduced LDH release, and inhibited apoptosis. By contrast, overexpression of miR-129 and miR-384-5p deficiency aggravated hypoxia-induced apoptosis and cell injury. miR-129 overexpression significantly reduced mRNA and protein levels of bcl-2 and miR-129 inhibition significantly increased mRNA and protein levels of bcl-2 in hypoxic cells.miR-384-5p overexpression significantly reduced protein levels of caspase-3 while miR-384-5p deficiency significantly increased protein levels of caspase-3. However, no changes were observed in caspase-3 mRNA in either transfection paradigm. Finally, luciferase reporter assay confirmed caspase-3 to be a direct target of miR-384-5p; however, no binding activity was detected between bcl-2 and miR-129.Transient cerebral ischemia induces differential expression of miR-129 and miR-384-5p which influences apoptosis by regulating apoptotic factors caspase-3 and bcl-2, thereby participating in the pathological mechanism of cerebral ischemia, and becoming potential targets for the treatment of ischemic cerebral injury in the future.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Apoptosis, bcl-2; Caspase-3, miR-129; Cerebral ischemia, oxygen glucose deprivation; miR-384-5p

Mesh:

Substances:

Year:  2021        PMID: 34661743     DOI: 10.1007/s00221-021-06236-z

Source DB:  PubMed          Journal:  Exp Brain Res        ISSN: 0014-4819            Impact factor:   1.972


  27 in total

Review 1.  The complexity of neurobiological processes in acute ischemic stroke.

Authors:  R Brouns; P P De Deyn
Journal:  Clin Neurol Neurosurg       Date:  2009-05-14       Impact factor: 1.876

2.  MicroRNA-384-5p Promotes Endothelial Progenitor Cell Proliferation and Angiogenesis in Cerebral Ischemic Stroke through the Delta-Likeligand 4-Mediated Notch Signaling Pathway.

Authors:  Jia Fan; Weiwei Xu; Shanji Nan; Meiji Chang; Yizhi Zhang
Journal:  Cerebrovasc Dis       Date:  2020-01-10       Impact factor: 2.762

3.  Overexpression of microRNA-378 attenuates ischemia-induced apoptosis by inhibiting caspase-3 expression in cardiac myocytes.

Authors:  Ji Fang; Xiao-Wei Song; Jing Tian; Hu-Yan Chen; Dong-Feng Li; Jian-Fei Wang; An-Jing Ren; Wen-Jun Yuan; Li Lin
Journal:  Apoptosis       Date:  2012-04       Impact factor: 4.677

Review 4.  Apoptotic mechanisms after cerebral ischemia.

Authors:  Brad R S Broughton; David C Reutens; Christopher G Sobey
Journal:  Stroke       Date:  2009-01-29       Impact factor: 7.914

5.  MicroRNA-384-5p regulates ischemia-induced cardioprotection by targeting phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta (PI3K p110δ).

Authors:  Yanyan Bao; Chengren Lin; Junguo Ren; Jianxun Liu
Journal:  Apoptosis       Date:  2013-03       Impact factor: 4.677

6.  Genomic profiling of microRNAs in bladder cancer: miR-129 is associated with poor outcome and promotes cell death in vitro.

Authors:  Lars Dyrskjøt; Marie S Ostenfeld; Jesper B Bramsen; Asli N Silahtaroglu; Philippe Lamy; Ramshanker Ramanathan; Niels Fristrup; Jens L Jensen; Claus L Andersen; Karsten Zieger; Sakari Kauppinen; Benedicte P Ulhøi; Jørgen Kjems; Michael Borre; Torben F Orntoft
Journal:  Cancer Res       Date:  2009-06-01       Impact factor: 12.701

7.  MiR-129-5p protects against myocardial ischemia-reperfusion injury via targeting HMGB1.

Authors:  Z-X Chen; D He; Q-W Mo; L-P Xie; J-R Liang; L Liu; W-J Fu
Journal:  Eur Rev Med Pharmacol Sci       Date:  2020-04       Impact factor: 3.507

8.  Trends in the incidence of ischaemic stroke in young adults between 1985 and 2011: the Dijon Stroke Registry.

Authors:  Yannick Béjot; Benoit Daubail; Agnès Jacquin; Jérôme Durier; Guy-Victor Osseby; Olivier Rouaud; Maurice Giroud
Journal:  J Neurol Neurosurg Psychiatry       Date:  2013-11-18       Impact factor: 10.154

Review 9.  Caspase inhibitors: prospective therapies for stroke.

Authors:  Nsikan Akpan; Carol M Troy
Journal:  Neuroscientist       Date:  2012-05-29       Impact factor: 7.235

Review 10.  Role of MicroRNAs in Parkinson's Disease.

Authors:  Suh Yee Goh; Yin Xia Chao; Shaikali Thameem Dheen; Eng-King Tan; Samuel Sam-Wah Tay
Journal:  Int J Mol Sci       Date:  2019-11-12       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.